William L. Dahut
American Cancer Society(US)National Institutes of Health(US)National Cancer Institute(US)Center for Cancer Research(US)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Cancer, Lipids, and Metabolism, Cancer Immunotherapy and Biomarkers, Prostate Cancer Diagnosis and Treatment, Immunotherapy and Immune Responses
Most-Cited Works
- → Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group(1999)982 cited
- → Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer(2010)969 cited
- → Risks of Proteinuria and Hypertension With Bevacizumab, an Antibody Against Vascular Endothelial Growth Factor: Systematic Review and Meta-Analysis(2007)623 cited
- → The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance(2019)374 cited
- → Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer(2005)369 cited
- → Randomized Phase II Trial of Docetaxel Plus Thalidomide in Androgen-Independent Prostate Cancer